← FDA Drug Approvals (Drugs@FDA)
RAMELTEON
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: I3 PHARMS · Approved 2020-04-10
Drug application
- FDA Application #
ANDA212650- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RAMELTEON
- Generic name
- RAMELTEON
- Active ingredients
- RAMELTEON
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- I3 PHARMS
- Manufacturer
- TruPharma, LLC
- First approval
- 2020-04-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown